Senators Ask FDA To Stop GM Salmon Review Process

Eleven coastal-state senators told the U.S. Food and Drug Administration that it should  discontinue its review of a genetically modified salmon because they believe the agency’s process is more suited to approving a new drug than a new human food. The AquAdvantage salmon was created using Chinook salmon growth hormone and genetic material from the eel-like pout to make it grow two times faster than natural Atlantic salmon. If okayed by the FDA, it would be the first GM animal approved for human consumption. The senators assert that the review process is keeping the public in the dark about the GM salmon, because the company is allowed to withhold some information submitted to the agency as confidential.